About Court Report: Each week we will report briefly on recently filed biotech and pharma cases.
AstraZeneca Pharmaceuticals LP et al. v. Pharmadax USA, Inc. et al. 1:14-cv-07105; filed November 3, 2014 in the...more
Endo Pharmaceuticals, Inc. v. Actavis, Inc., et al.
Case Number: 1:12-cv-08985-TPG (Dkt.55) -
Endo brought suit against Actavis, as well as over a dozen other pharmaceutical manufacturers, for allegedly...more
Endo Pharmaceuticals Inc. et al. v. Teva Pharmaceuticals USA, Inc. et al. Inter Partes Review.
Case Number: 1:12-cv-08060-GWG (Dkt. 68) -
One of twelve defendants in patent suits brought by Endo petitioned the...more
Pharmaceutical Facility Inspection Leads to Manufacturer Warning -
After a recent inspection of a pharmaceutical manufacturing facility belonging to Endo International PLC, the U.S. Food and Drug Administration (FDA)...more
Case Name: Endo Pharms. Inc. v. Actavis, Inc., Nos. 2013-1658, -1662, 2014 U.S. App. LEXIS 5879 (Fed. Cir. Mar. 31, 2014) (Circuit Judges Newman, Dyk, and Moore presiding; Opinion by Moore, J.; Dissent-in-part by Dyk) (appeal...more
Endo Pharmaceuticals Inc. v. Actavis, Inc. -
Addressing the issue of implied license, the U.S. Court of Appeals for the Federal Circuit vacated and remanded a lower court’s denial of a preliminary injunction, finding...more
Case Number: 1:12-cv-09261-TPG (Dkt. 76) -
The court denied plaintiffs’ motion to bar Par’s expert Professor Midian from receiving any of their confidential information unless he agreed to a patent prosecution bar. ...more
Back to Top